glp 1 qualification 📣 Medicare beneficiaries: there's a new program worth knowing about. Beginning July 1, 2026, the CMS GLP-1 Bridge Program may help eligible Medicare patients access certain weight management medications at a lower HINES CLINICAL GLP-1 WEIGHT MANAGEMENT

Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields

If you have a risk version, you are more likely to have high Lp(a) on a blood test

Lot:VL-BPC-2026-0412 BPC-157 is a synthetic peptide sequence referenced extensively in in vitro and preclinical research literature

Compound time-of-addition (TOA) analysis suggests differential modes of antiviral activity In order to get first insights into the potential mode-of-action exerted by the two compounds against the viruses investigated, we performed time-of-addition assays